Insulin Sensitivity: Clinical Trials

6 trials for Insulin Sensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 31Completed 1

Follow Insulin Sensitivity: new trials by email Literature Review of Insulin Sensitivity trials Research Report on Insulin Sensitivity

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of TLR4 on Lipid-induced Insulin Resistance
Eritoran, D5W (5% Dextrose in water) - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio102015-01-012019-10-08
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
Maltodextrin, Synbiotic, Sevelamer - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio692014-04-102020-09-11
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)
Sevelamer, Synbiotic, Maltodextrin - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio202014-04-022021-10-15
Vitamin D AND Glucose Handling Evaluated by Glucose Clamp
cholecalciferol - Insulin Sensitivity, Intraocular Pressure
Phase 2CompletedUniversity Hospital of North Norway1602008-11-012011-11-03
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
Intralipid, ClinOleic, Dextrose - Diseases, Metabolic, Insulin Sensitivity
Phase 2 / Phase 3CompletedEmory University122008-06-012014-12-31
The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects
Gemcabene 900 mg, Placebo - Insulin Sensitivity
Phase 2CompletedNeuroBo Pharmaceuticals Inc.532001-07-012020-04-09

Narrower conditions

Insulin Resistance (6)  ·  Metabolic Diseases (1)

Broader conditions

Glucose Metabolism Disorders (6)  ·  Hyperinsulinism (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Metabolic Diseases (5)

Interventions

Glucose (2)  ·  Sevelamer (2)  ·  Synbiotics (2)  ·  maltodextrin (2)  ·  Cholecalciferol (1)  ·  ClinOleic (1)  ·  Diet (1)  ·  Diet, Fat-Restricted (1)  ·  Diet, High-Fat (1)  ·  E5564 (1)  ·  Sodium Chloride (1)  ·  Water (1)  ·  eritoran (1)  ·  gemcabene (1)  ·  soybean oil, phospholipid emulsion (1)

Sponsors

The University of Texas Health Science Center at San Antonio (3)  ·  Emory University (1)  ·  NeuroBo Pharmaceuticals Inc. (1)  ·  University Hospital of North Norway (1)

Countries

United States (4)  ·  Norway (1)

Top investigators

Nicolas Musi, MD. (2)  ·  Guillermo Umpierrez, MD (1)  ·  Nicolas Musi, MD (1)  ·  Rolf Jorde, Professor (1)

Results publications

PMID 21832112, PMID 21911741, PMID 36066991, PMID 42141362